November 2016 - FRMC

Department

Managed Care Q&A

Quality Care: A Unique Perspective Part 2

12/09/2016

Dean Celia

Margaret E O’Kane continues the discussion on the evolution of quality care, including challenges that have been overcome and those that remain.

Margaret E O’Kane continues the...

12/09/2016

First Report Managed Care

News Connection

Push to Address High Drug Prices Could Table Cure Act

11/27/2016

The future of the 21st Century Cure Act, which includes funds for medical research and aims to speed up the FDA's drug approval process, is up in the air following a recent push from patient advocacy and union groups to hold the bill until...

The future of the 21st Century...

11/27/2016

First Report Managed Care

Managed Care Q&A

Improving Diabetes Awareness Through Managed Care

11/22/2016

David Costill

An interview with Albert Tzeel, MD, regional medical director, Humana

An interview with Albert Tzeel,...

11/22/2016

First Report Managed Care

News Connection

Investigational Biologic Benefits Patients With Multidrug-Resistant HIV in Phase 3 Trial

11/22/2016

Treatment with the investigational biologic ibalizumab (TaiMed Biologics/Theratechnologies) appeared to safely reduce the viral loads of patients with multidrug-resistant HIV, according to late-breaking phase III trial results recently...

Treatment with the...

11/22/2016

First Report Managed Care

News Connection

Investigational Dupixent Significantly Eases Uncontrolled Atopic Dermatitis

11/22/2016

A pair of identically designed phase 3 trials found that Dupixent (dupilumab; Sanofi/Regeneron) improved symptoms of moderate-to-severe atopic dermatitis, including itching, anxiety and depression, and quality of life, compared with placebo.

A pair of identically designed...

11/22/2016

First Report Managed Care

News Connection

Lynparza Lengthens Survival in Women with Ovarian Cancer

11/22/2016

Women who took Lynparza (olaparib; AstraZeneca) tablets as a monotherapy for maintenance treatment of platinum-sensitive relapsed BRCA-mutated ovarian cancer showed significantly improved progression-free survival compared with women who took...

Women who took Lynparza...

11/22/2016

First Report Managed Care

News Connection

Amyloid Positron Emission Tomography Improves Diagnosis, Management of Alzheimer Disease

11/22/2016

A recently study suggests amyloid positron emission tomography alongside routine cognitive impairment assessment may improve physicians’ diagnosis and management of Alzheimer disease.

A recently study suggests...

11/22/2016

First Report Managed Care

News Connection

Mail-Order Pharmacies Potentially Linked to Higher Medication Adherence

11/22/2016

Recent data show higher medical adherence by patients who use mail-order pharmacies compared to those who use retail pharmacies, although more research is still needed.

Recent data show higher medical...

11/22/2016

First Report Managed Care

News Connection

Results Mixed for PCMH Diabetes Care

11/22/2016

Results of a new study suggest that patient-centered medical homes (PCMHs) have diverse effects on different outcomes for diabetes care.

Results of a new study suggest...

11/22/2016

First Report Managed Care

News Connection

Five Groups Express Concern Over Extending Biologic Competition Protection Under the TPP

11/22/2016

In a recent letter, a group of physician, consumer, and employment groups urged President Obama to waive agreements that would lengthen data protections for biologic medicines in an expansive Asia-Pacific trade deal.

In a recent letter, a group of...

11/22/2016

First Report Managed Care

Behind the Bill

SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power

04/02/2025

Katie Hayes, MJ

The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...

The Supreme Court recently heard...

04/02/2025

First Report Managed Care

Behind the Bill

Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”

03/26/2025

Katie Hayes, MJ

On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...

On Tuesday, March 25, 2025, the...

03/26/2025

First Report Managed Care

Behind the Bill

The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid

03/19/2025

Katie Hayes, MJ

Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...

Last week, I explored the $880...

03/19/2025

First Report Managed Care

Behind the Bill

The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?

03/12/2025

Katie Hayes, MJ

I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...

I’d like to step away from...

03/12/2025

First Report Managed Care

Behind the Bill

RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking

03/05/2025

Katie Hayes, MJ

The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...

The erosion of administrative...

03/05/2025

First Report Managed Care

Behind the Bill

Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction

02/26/2025

Katie Hayes, MJ

The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...

The dust has barely settled from...

02/26/2025

First Report Managed Care

Behind the Bill

The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)

02/19/2025

Katie Hayes, MJ

Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...

Last week, I explored the...

02/19/2025

First Report Managed Care

Behind the Bill

The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)

02/12/2025

Katie Hayes, MJ

Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...

Just when you thought the dust...

02/12/2025

First Report Managed Care

Behind the Bill

No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries

02/05/2025

Katie Hayes, MJ

On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...

On inauguration day, President...

02/05/2025

First Report Managed Care

Behind the Bill

Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate

01/29/2025

Katie Hayes, MJ

The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...

The Plot Thickens in Drug...

01/29/2025

First Report Managed Care